| Abstract: |
In standard 3H-opioid binding assays, the benzoylhydrazone derivative of naloxone (6-desoxy-6-benzoylhydrazido-N-allyl-14-hydroxydihydronormorphinone; Nh alBzoH) inhibited μ, κ, and δ binding at nanomolar concentrations. At concentrations as low as 1 nM, it also produced a wash-resistant inhibition of opioid binding. [3H]NalBzoH binding typically gave a ratio of total to nonspecific binding of 8:1. Binding reached state levels by 1 hr and was linear with tissue concentration. [3H]NalBzoH labeled two classes of sites. The binding to one was easily reversible whereas the other was not and was termed pseudoir-reversible. At 25°, almost 90% of [3H]naloxone binding and approximately 60-75% of [3H]NalBzoH binding dissociated over 90 min. However, the remainder of [3H]NalBzoH binding, corresponding to pseudoirreversible binding, remained constant over the next 5 hr at 25° and additional studies suggested a dissociation half-life of approximately 24 hr. Competition studies indicated that the reversible binding corresponded to neither μ nor δ binding and may represent a novel subtype of κ receptor. Pseudoirreversible binding was predominantly to a combination of both μ1 and μ2 receptors. Despite its extremely slow rate of dissociation, pseudoirreversible binding was not covalent inasmuch as lowering the pH to 5 or adding the GTP analog 5'-guanylylimidodiphosphate [Gpp(NH)p] completely dissociated prebound [3H]NalBzoH. The ability of Gpp(NH)p to dissociate pseudoirreversible [3H]NalBsoH binding raised the possibility that the slow rate of dissociation was related to interactions with a guanine nucleotide-binding protein. |
| Keywords: |
unclassified drug; nonhuman; animal cell; animal; metabolism; ph; in vitro study; drug effect; drug receptor binding; kinetics; diagnostic agent; brain; drug derivative; cattle; radioisotope; morphine; mu opiate receptor; receptors, opioid, mu; in vitro; naloxone; corpus striatum; opiate receptor; 3,4 dichloro n methyl n [2 (1 pyrrolidinyl)cyclohexyl]benzeneacetamide; tritium; pyrrolidines; delta opiate receptor; naloxone benzoylhydrazone; drug concentration; kappa opiate receptor; levallorphan; brain membrane; receptors, opioid; priority journal; article; receptors, opioid, kappa; enkephalin derivative; pyrrolidine derivative; support, u.s. gov't, p.h.s.; enkephalin[2 dextro alanine 5 dextro leucine]; 3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-isomer; guanylylimidodiphosphate; guanylyl imidodiphosphate; benzoylhydrazone derivative; 3,4 dichloro n methyl n (2 (1 pyrrolidinyl) cyclohexyl) benzeneacetamide, (trans) isomer
|
